Big Gain For Quince Therapeutics Inc Com
Fri, Jan 27, 2023 at 07:00 PM
Quince Therapeutics Inc Com (QNCX:NASDAQ) jumped higher at $1.08, a gain of 33.7%. On Fri, Jan 27, 2023, QNCX:NASDAQ hit a New 2-Week High of $1.08. From Fri, Jan 13, 2023, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Fri, Jan 27, 2023 at $1.47 with a volume of 63M+.
About Quince Therapeutics Inc Com (QNCX:NASDAQ)
Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases.
Top 10 Gainers:
- Schmitt Industries, Inc. (SMIT:NASDAQ), 282%
- FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 95.86%
- BuzzFeed Inc. (BZFD:NASDAQ), 85.17%
- Polished Inc Com (POL:NYSEMKT), 55.7%
- Applied UV Inc. (AUVI:NASDAQ), 52.88%
- Lucid Group Inc. (LCID:NASDAQ), 43%
- VivoPower International PLC (VVPR:NASDAQ), 36.99%
- Quince Therapeutics Inc Com (QNCX:NASDAQ), 33.66%
- Phoenix Motor Inc. (PEV:NASDAQ), 30.63%
- CN Energy Group Inc. (CNEY:NASDAQ), 29.17%